CTCE-9908

Star0

DB05625InvestigationalSmall molecule

Investigated for use/treatment in cancer/tumors (unspecified), lung cancer, and sarcoma.

Mechanism: Pharmacologically active on C-X-C chemokine receptor type 4
Curator reviewed
Primary indication: Investigated for use/treatment in cancer/tumors (unspecified), lung cancer, and sarcoma.Curator reviewed
Formula / weight: C₈₆H₁₄₇N₂₇O₂₃ · 1927.288 g/mol (avg)
Also known as: SDF-1 (108) Lysine Dlmer
Code names: CTCE-9908 · PTX-9908 FREE BASE

Resolves to

Compound

UNIINF0BX95A31CAS1030384-98-5ChEMBLCHEMBL3544949

Structure

InChIKeyVUYRSKROGTWHDC-HZGLMRDYSA-NSMILES

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O

Targets

P61073CXCR4

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with CTCE-9908, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account